Unknown

Dataset Information

0

Anti-PD1 and anti-PD-L1 in the treatment of metastatic melanoma.


ABSTRACT: Programmed cell death receptor-1 (PD-1) and programmed cell death-1 ligand-1 (PD-L1) represent promising novel targets in immunotherapy. PD-1 is an inhibitory receptor involved in T-cell regulation that is expressed by activated T cells. Nivolumab and pembrolizumab are anti-PD-1 antibodies that have shown antitumor activity and acceptable tolerability in patients with metastatic melanoma in preclinical development and Phase I/II clinical trials. Several ongoing Phase III studies are further investigating the efficacy and safety of anti-PD-1 therapy in melanoma. Initial data on the combination of anti-PD-1 and anti-cytotoxic T-lymphocyte-associated antigen 4 blockade with nivolumab and ipilimumab also appear promising. Monoclonal antibodies to blockade PD-L1 may also be an effective immunotherapy strategy in melanoma and several anti-PD-L1 antibodies are in development.

SUBMITTER: Simeone E 

PROVIDER: S-EPMC6094609 | biostudies-literature | 2015 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Anti-PD1 and anti-PD-L1 in the treatment of metastatic melanoma.

Simeone Ester E   Grimaldi Antonio M AM   Ascierto Paolo A PA  

Melanoma management 20150225 1


Programmed cell death receptor-1 (PD-1) and programmed cell death-1 ligand-1 (PD-L1) represent promising novel targets in immunotherapy. PD-1 is an inhibitory receptor involved in T-cell regulation that is expressed by activated T cells. Nivolumab and pembrolizumab are anti-PD-1 antibodies that have shown antitumor activity and acceptable tolerability in patients with metastatic melanoma in preclinical development and Phase I/II clinical trials. Several ongoing Phase III studies are further inve  ...[more]

Similar Datasets

| S-EPMC7223273 | biostudies-literature
| S-EPMC9974984 | biostudies-literature
| S-EPMC5142752 | biostudies-literature
| S-EPMC5504332 | biostudies-other
| S-EPMC8764806 | biostudies-literature
2023-03-08 | GSE223110 | GEO
| S-EPMC7409244 | biostudies-literature
| S-EPMC7881100 | biostudies-literature
| S-EPMC5767160 | biostudies-other
| S-EPMC8261162 | biostudies-literature